Tin tức & Cập nhật

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023 bởi

Treatment with a single oral dose of azithromycin, given to women in labour who were planning a vaginal birth, significantly reduced the risk of maternal death or sepsis, according to the A-PLUS* trial presented at SMFM 2023.

Single-dose azithromycin during labour prevents maternal death, sepsis

15 Feb 2023

Elinzanetant a promising nonhormone treatment option for VMS, sleep problems

14 Feb 2023 bởi

The selective neurokinin (NK)-1,3 receptor antagonist elinzanetant appears to be beneficial in the treatment of vasomotor symptoms (VMS) and associated sleep disturbance in postmenopausal women, as shown in the results of the phase IIb SWITCH-1 trial.

Elinzanetant a promising nonhormone treatment option for VMS, sleep problems

14 Feb 2023

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status

11 Feb 2023

Neither vulvovaginal candidiasis nor bacterial vaginosis is associated with increased incidence of cervical cytologic abnormalities among women with or without human papillomavirus (HPV) infection, according to a study. Bacterial vaginosis may even have a protective effect against cytologic abnormalities among women with HPV coinfection.

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status

11 Feb 2023

Adverse pregnancy outcomes implicated in coronary artery disease

10 Feb 2023

Coronary artery disease appears to be common among women with a history of adverse pregnancy outcomes, including those estimated to be at low risk of cardiovascular disease, according to a study.

Adverse pregnancy outcomes implicated in coronary artery disease

10 Feb 2023

Obesity tied to gestational diabetes risk

08 Feb 2023

Obesity appears to exert a detrimental causal effect on the risk of gestational diabetes, with lipid metabolism acting as a potential driver of the relationship, according to the results of a Mendelian randomization analysis.

Obesity tied to gestational diabetes risk

08 Feb 2023

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

06 Feb 2023 bởi

The use of low-molecular-weight heparin (LMWH) during pregnancy did not increase the likelihood of live birth compared with standard surveillance in women with inherited thrombophilia who have experienced multiple miscarriages, according to a multinational study presented at ASH 2022.

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

06 Feb 2023

Buprenorphine use during pregnancy linked to better neonatal outcomes

06 Feb 2023 bởi

The use of buprenorphine during pregnancy appears to be associated with a lower risk of adverse neonatal outcomes compared with methadone use. However, adverse maternal outcomes are similar for both therapies, according to a recent study.

Buprenorphine use during pregnancy linked to better neonatal outcomes

06 Feb 2023

Letrozole outperforms clomiphene citrate for ovulation induction

06 Feb 2023

The use of letrozole for inducing ovulation in women with infertility and polycystic ovarian syndrome (PCOS) appears to yield improvements in ovulation, pregnancy, and live-birth rates as compared with clomiphene citrate, according to a study.

Letrozole outperforms clomiphene citrate for ovulation induction

06 Feb 2023

Original New Drug Application Approvals by US FDA (16-31 January 2023)

31 Jan 2023

New drug applications approved by US FDA as of 16-31 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 January 2023)

31 Jan 2023

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

29 Jan 2023

Women with vulvovaginal atrophy exhibit a less favourable vaginal microbiome than healthy postmenopausal women, but ospemifene may restore vaginal health by reducing potentially harmful bacteria, as shown in a study.

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

29 Jan 2023

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Single-dose azithromycin during labour prevents maternal death, sepsis

Single-dose azithromycin during labour prevents maternal death, sepsis

Elinzanetant a promising nonhormone treatment option for VMS, sleep problems

Elinzanetant a promising nonhormone treatment option for VMS, sleep problems

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status

Genital tract infections not a risk factor for cytologic abnormalities regardless of HPV infection status

Adverse pregnancy outcomes implicated in coronary artery disease

Adverse pregnancy outcomes implicated in coronary artery disease

Obesity tied to gestational diabetes risk

Obesity tied to gestational diabetes risk

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

Buprenorphine use during pregnancy linked to better neonatal outcomes

Buprenorphine use during pregnancy linked to better neonatal outcomes

Letrozole outperforms clomiphene citrate for ovulation induction

Letrozole outperforms clomiphene citrate for ovulation induction

Original New Drug Application Approvals by US FDA (16-31 January 2023)

Original New Drug Application Approvals by US FDA (16-31 January 2023)

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy